Actively Recruiting

Phase Not Applicable
Age: 18Years - 60Years
All Genders
ID04663724

Computer-Based Treatment for Social Anxiety Disorder, A Randomized Controlled Trial

Led by New York State Psychiatric Institute · Updated on 2026-06-01

80

Participants Needed

1

Research Sites

12 weeks

Total Duration

On this page

Sponsors

N

New York State Psychiatric Institute

Lead Sponsor

C

Columbia University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a new computer-based therapy designed for individuals with social anxiety disorder (SAD). This randomized clinical trial aims to study the feasibility, acceptability, how the therapy works, and its effectiveness in improving social anxiety symptoms. The study also investigates changes in brain activity using magnetic resonance imaging (MRI) to better understand the treatment's impact. Participants will undergo a 4-week treatment program consisting of eight sessions. Each session lasts 30 minutes and involves viewing pictures of faces, sometimes accompanied by music. Treatments are delivered twice a week over the four-week period. The study includes two groups receiving different forms of this computer-based therapy for comparison. During the trial, participants will be assessed using various scales measuring social anxiety and quality of life at the start and up to four months later. Evaluations include brain scans with MRI, questionnaires, and clinical impressions to monitor changes and treatment effects. The trial is designed to carefully track participants' progress and safety throughout the study period.

CONDITIONS

Brief Title

Computer - Based Treatment for Social Anxiety Disorder

Who Can Participate

Age: 18Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Males and females between the ages of 18 to 60
  • Current primary diagnosis of social anxiety disorder (SAD)
  • Score of at least 50 on the Liebowitz Social Anxiety Scale (self-rated version)
  • Fluent in English
  • Willing and able to give informed written consent
  • Ability to participate responsibly in the protocol
  • Normal or corrected-to-normal vision
Not Eligible

You will not qualify if you...

  • Present or past psychotic episode, psychotic disorder, schizophrenia, schizoaffective disorder, or bipolar disorder
  • Current severe depression
  • Suicidal ideation or behavior
  • Current diagnosis of post-traumatic stress disorder, obsessive-compulsive disorder, bipolar disorder, manic episode, or tic disorder
  • Current or past organic mental disorder, seizure disorder, epilepsy, or brain injury
  • Current unstable or untreated medical illness
  • Severe alcohol use disorder, severe cannabis use disorder, or any severity of other substance use disorder (except nicotine use disorders)
  • Use of psychiatric medication in the past month other than a stable dose of selective serotonin reuptake inhibitors (SSRIs) for at least 3 months
  • Any concurrent cognitive behavioral therapy or other psychotherapy started in the past 3 months
  • Pregnancy or plans to become pregnant during the study period
  • Contraindication to MRI scanning such as pacemaker, paramagnetic metallic prosthesis, surgical clips, shrapnel, constant medicinal patch, or some tattoos
  • Inability to tolerate MRI scanning procedures like severe obesity or claustrophobia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 4 weeks

Participants undergo a 4-week computer-based treatment involving eight 30-minute sessions. Treatments occur twice a week and involve viewing pictures of faces while music may play.

2 visits per week for 4 weeks

Follow-up

Duration - Up to 4 months

Participants are monitored for changes in social anxiety symptoms and quality of life up to 4 months after treatment completion.

Visits scheduled as needed up to Month 4

Trial Site Locations

Total: 1 location

1

1051 Riverside Drive

New York, New York, United States, 10032

Actively Recruiting

Loading map...

Research Team

F

Franklin Schneier, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Fasedienol Nasal Spray for Acute Anxiety Treatment in Adults...

Social Anxiety Disorder

Actively Recruiting

9 locations

The Effect of a Transdiagnostic, Self-guided Internet Interv...

Panic Disorder With Agoraphobia

Actively Recruiting

1 location

An Examination of the Performance of QbMobile in Differentia...

Bi-Polar Disorder

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here